Not sure what your qualifications are, heard you claimed you are better qualified than all IMU staff together, you should know this why a product does not make it to some reports, I can think of 2, 3rd is my ideal outcome, which is a deal incoming1. Focussing on Key Milestones - Annual reports often prioritize key financials and major developments. If HER-Vaxx hasn’t yet generated substantial data or financial impacts yet, IMU might had focussed on other aspects of its pipeline or more advanced projects.
2. Regulatory and Legal Consideration - IMU are sometimes cautious about providing detailed updates on ongoing clinical trials due to regulatory or legal risks, especially if results are preliminary and not yet peer-reviewed or conclusive
But why did you omit "ACTIVE" status from your message and took only "not recruiting" interesting guy hmmm
Wher is Ben, Davy, Zior ?, page-33
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.7¢ | $2.298M | 47.86M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 1925982 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3452098 | 12 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |